The parasitic protozoan Leishmania donovani is the causative organism for visceral leishmaniasis (VL) which persists in the host macrophages by deactivating its signaling machinery resulting in a critical shift from proinflammatory (Th1) to an anti-inflammatory (Th2) response. The severity of this disease is mainly determined by the production of IL-12 and IL-10 which could be reversed by use of effective immunoprophylactics. In this study we have evaluated the potential of Arabinosylated Lipoarabinomannan (Ara-LAM), a cell wall glycolipid isolated from non pathogenic Mycobacterium smegmatis, in regulating the host effector response via effective regulation of mitogen-activated protein kinases (MAPK) signaling cascades in Leishmania donovani infected macrophages isolated from BALB/C mice. Ara-LAM, a Toll-like receptor 2 (TLR2) specific ligand, was found to activate p38 MAPK signaling along with subsequent abrogation of extracellular signal–regulated kinase (ERKs) signaling. The use of pharmacological inhibitors of p38MAPK and ERK signaling showed the importance of these signaling pathways in the regulation of IL-10 and IL-12 in Ara-LAM pretreated parasitized macrophages. Molecular characterization of this regulation of IL-10 and IL-12 was revealed by chromatin immunoprecipitation assay (CHIP) which showed that in Ara-LAM pretreated parasitized murine macrophages there was a significant induction of IL-12 by selective phosphorylation and acetylation of histone H3 residues at its promoter region. While, IL-10 production was attenuated by Ara-LAM pretreatment via abrogation of histone H3 phosphorylation and acetylation at its promoter region. This Ara-LAM mediated antagonistic regulations in the induction of IL-10 and IL-12 genes were further correlated to changes in the transcriptional regulators Signal transducer and activator of transcription 3 (STAT3) and Suppressor of cytokine signaling 3 (SOCS3). These results demonstrate the crucial role played by Ara-LAM in regulating the MAPK signaling pathway along with subsequent changes in host effector response during VL which might provide crucial clues in understanding the Ara-LAM mediated protection during Leishmania induced pathogenesis.
References
[1]
Descoteaux A, Matlashewski G (1989) c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages. Mol Cell Biol 9: 5223–7.
[2]
Murray HW, Spitalny GL, Nathan CF (1985) Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. J Immunol 134: 1619–1622.
[3]
Russell DG, Talamas-Rohana P (1989) Leishmania and the macrophage: a marriage of Inconvenience. Immunol Today 10: 328–33.
[4]
Murray HW (1982) Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. J Immunol 129: 351–7.
[5]
Liew FY, Millott S, Parkinson C, Palmer RM, Moncada S (1990) Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol 144: 4794–7.
[6]
Reiner SL, Locksley RM (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol 13: 151–177.
[7]
Bacellar O, D'oliveira A Jr, Jer？nimo S, Carvalho EM (2000) IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine 12: 1228–31.
[8]
Bhattacharya P, Bhattacharjee S, Gupta G, Majumder S, Adhikari A, et al. (2010) Arabinosylated lipoarabinomannan-mediated protection in visceral leishmaniasis through up-regulation of toll-like receptor 2 signaling: an immunoprophylactic approach. J Infect Dis 202: 145–55.
[9]
Pan ZK (2004) Toll-like receptors and TLR-mediated signaling: more questions than answers. Am J Physiol Lung Cell Mol Physiol 286(5): L918–20.
[10]
Cano E, Mahadevan LC (1995) Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20: 117–22.
[11]
Clayton AL, Mahadevan LC (2003) MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett 546: 51–8.
[12]
Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B (2004) Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med 10: 540–4.
[13]
Saccani S, Pantano S, Natoli G (2002) p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 1: 69–75.
[14]
Lucas M, Zhang X, Prasanna V, Mosser DM (2005) ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J Immunol 175: 469–77.
[15]
Hoentjen F, Sartor RB, Ozaki M, Jobin C (2005) STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 105: 689–96.
[16]
Qasimi P, Ming-Lum A, Ghanipour A, Ong CJ, Cox ME, et al. (2006) Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophages. J Biol Chem 281: 6316–24.
[17]
Qin H, Roberts KL, Niyongere SA, Cong Y, Elson CO, et al. (2007) Molecular mechanism of lipopolysaccharide-induced SOCS3 gene expression in macrophages and microglia. J Immunol 179: 5966–76.
[18]
Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, et al. (1999) Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol 163: 6403–12.
[19]
Suttles J, Milhorn DM, Miller RW, Poe JC, Wahl LM, et al. (1999) CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action. J Biol Chem 274: 5835–42.
Li Y, Chu N, Rostami A, Zhang GX (2006) Dendritic cells transduced with SOCS3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiations in vitro and in vivo. J Immunol 177: 1679–88.
[22]
Chakraborty D, Banerjee S, Sen A, Banerjee KK, Das P, et al. (2005) Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol 175: 3214–24.
[23]
Reiner NE (1994) Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol Today 15: 374–381.
[24]
Awasthi A, Mathur R, Khan A, Joshi BN, Jain N, et al. (2003) CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response. J Exp Med 197: 1037–43.
[25]
Yang Z, Mosser DM, Zhang X (2007) Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J Immunol 178: 1077–1085.
[26]
Briken V, Porcelli SA, Besra GS, Kremer L (2004) Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 53: 391–403.
[27]
Nigou J, Gilleron M, Puzo G (2003) Lipoarabinomannans: from structure to biosynthesis. Biochimie 85: 153–66.
[28]
Bohsali A, Abdalla H, Velmurugan K, Briken V (2010) The non-pathogenic mycobacteria M. smegmatis and M. fortuitum induce rapid host cell apoptosis via a caspase-3 and TNF dependent pathway. BMC Microbiol 10: 237.
[29]
Imai K, Kurita-Ochiai T, Ochiai K (2003) Mycobacterium bovis bacillus Calmette-Guérin infection promotes SOCS induction and inhibits IFN-gamma-stimulated JAK/STAT signaling in J774 macrophages. FEMS Immunol Med Microbiol 39: 173–80.
[30]
de Veer MJ, Curtis JM, Baldwin TM, DiDonato JA, Sexton A, et al. (2003) MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol 33: 2822–31.
[31]
Stoiber D, Stockinger S, Steinlein P, Kovarik J, Decker T (2001) Listeria monocytogenes modulates macrophage cytokine responses through STAT serine phosphorylation and the induction of suppressor of cytokine signaling 3. J Immunol 166: 466–72.
[32]
Suhrbier A, La Linn M (2003) Suppression of antiviral responses by antibody-dependent enhancement of macrophage infection. Trends Immunol 24: 165–8.
[33]
Dennis V, Kaushal D, Dixit S, Mehra S, Singh S, et al. (2008) SOCS3 and IL-10 anti-inflammatory activity in Lyme disease. The FASEB Journal 22: 860.17.
[34]
Hart DT, Vickerman K, Coombs GH, Quick A (1981) Simple method for purifying L. mexicana amastigotes in large numbers. Parasitology 82: 345–355.
[35]
Majumder N, Dey R, Mathur RK, Datta S, Maitra M, et al. (2006) An unusual pro-inflammatory role of interleukin-10 induced by arabinosylated lipoarabinomannan in murine peritoneal macrophages. Glycoconj J 23: 675–686.
[36]
Bhattacharjee S, Majumder N, Bhattacharyya P, Bhattacharyya S, Majumdar S (2007) Immunomodulatory role of arabinosylated lipoarabinomannan on Leishmania donovani infected murine macrophages. Indian J Biochem Biophys 44: 366–372.
Bhattacharyya S, Ghosh S, Dasgupta B, Mazumder D, Roy S, Majumdar S (2002) Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. J Infect Dis 185: 1704–8.
[39]
Majumdar S, Kane LH, Rossi MW, Volpp BD, Nauseef WM, et al. (1993) Protein kinase C isotypes and signal transduction in human neutrophils: selective substrate specificity of calcium dependent b-PKC and novel calcium independent n-PKC. Biochim Biophys Acta 1176: 276–286.
[40]
Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, et al. (2002) Leishmania donovani suppresses activator protein-1 and NF-kB in host macrophages via ceramide generation: involvement of extracellular signal regulated kinase. Infect Immun 70: 6828–6838.
[41]
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, et al. (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126: 131–138.
[42]
Roy S, Scherer MT, Briner TJ, Smith JA, Gefter LM (1989) Murine MHC polymorphism and T cell specificities. Science 244: 572–5.
[43]
Yaron A, Gonen H, Alkalay I, Hatzobai A, Jung S, et al. (1997) Inhibition of NF-κ-B cellular function via specific targeting of the I-κ-B-ubiquitin ligase. EMBO J 16: 6486–6494.
[44]
Chomezynasky P, Sacchi N (1987) A single step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–9.
[45]
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, , NY: Cold Spring Harbor Laboratory Press.
